Liver Cancer

Hepatocellular Carcinoma (HCC), also known as liver cancer, is a severe disease due to its high prevalence and poor prognosis. More than half a million cases are reported annually and the number is estimated to rise as Hepatitis C (HCV) rates of infection and improved clinical management of liver cirrhosis increase. Prognosis depends on the stage of the cancer; less than 3 months in very advanced tumors. The size of a tumor influences directly the possibility of surgical or ablative interventions, and a small tumor has a better chance of being cured.

Related Products

	An immunohistochemical kit for the detection of Hepatocellular Carcinoma (HCC) from liver biopsies
	ELISA Kit for the detection of Squamous Cell Carcinoma Antigen variants Immune Complexes (SCCA-IgM)
	ELISA Kit for the detection of Alpha-Fetoprotein (AFP) Immune Complexes in Hepatocellular Carcinoma (HCC)
	A new index to identify the risk of developing non-alcoholic steatohepatitis (NASH)